What predicts survival in severe kidney infections? new study digs into the data
NCT ID NCT06299215
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study reviewed 575 adults admitted to intensive care for a severe kidney infection called acute obstructive pyelonephritis. Researchers aimed to identify factors that lead to poor outcomes such as death or lasting kidney damage. The goal is to better understand which patients are at highest risk and may need more aggressive care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
575 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients meeting the eligibility criteria over the period 2015-2022 will be included in the study.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 18 years of age * Hospitalized in intensive care for management of acute obstructive pyelonephritis * Patients affiliated to a Social Security System Exclusion Criteria: * Pregnancy * Opposition to data use * Persons under legal protection (curatorship, guardianship), legal safeguards
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute obstructive pyelonephritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Saint Louis
Paris, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.